Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase refers to a large superfamily of enzymes that catalyze the removal of a phosphate group from phosphorylated proteins—a critical process for the regulation of cellular signaling. Protein phosphatases counterbalance the actions of protein kinases, maintaining cell homeostasis through reversible phosphorylation. They are broadly classified by substrate specificity and structural features into serine/threonine phosphatases (PPP, PPM, Asp-based), tyrosine phosphatases (PTP), and dual-specific phosphatases. Prominent members include protein phosphatase 1 (PP1), protein phosphatase 2A (PP2A), protein phosphatase 2B (calcineurin/PP2B), and protein phosphatase 2C (PP2C/PPM1). They play essential roles in cell cycle progression, apoptosis, cell signaling, and stress responses. Dysfunction or dysregulation of specific protein phosphatases is implicated in cancer, neurodegeneration, cardiovascular diseases, and other pathologies[1][3][5]. Due to their central roles, select protein phosphatases—especially calcineurin—are important drug targets (e.g., by immunosuppressants such as cyclosporine and tacrolimus), but the broad and highly conserved nature of these enzyme families poses challenges for therapeutic specificity and safety[3][5][8]. **Important caveat:** "Protein phosphatase" as a target is a superfamily name and lacks specificity. Research, clinical targeting, and biomarker applications typically relate to individual isoforms (e.g., PP2A, PP1, calcineurin/PP2B, PPM1D), each with distinct biology and pharmacology. Therefore, this entry is too general for drug development or biomarker strategies. A more specific target, such as "Protein phosphatase 2A," should be used for structured annotation or therapeutic purposes[1][2][4][6].
Inhibition of phosphatase activity (immunosuppression by calcineurin inhibition, toxin-induced phosphatase inhibition, etc.) Modulation of cell signaling by altering protein phosphorylation state
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase (PP (generic; specific isoforms include PP1, PP2A, PP2B, etc.)).